Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
Overview of the CLLR3 trial of obinutuzumab
What are the best molecular diagnostic techniques in CLL?
Do CLL patients with mutated immunoglobulin receptors respond better to therapy?